Dear ASCO Member Letter From Klausner Attempts To Rescue Flagging BMT Trial.
McKay Retires As Fox Chase Executive, Is Succeeded By Donald Leedy As VP.
ASCO Foundation Raised $200,000 In Its First Year.
ASCO Selects Three Cities For Quality Of Care Study.
Early Detection Network Completes Initial Funding From NCI.
FDA Approves Mylotarg For First Relapse Of Acute Myeloid Leukemia In Patients 60+.
Pharmacia Corp. Forms $1 Million Fund To Support Anthracycline Research.
One Health Plan, Genzyme Agree On Genetic Testing.
ECOG To Cease Participation In Melanoma Vaccine Study.
Vysis, Genentech In Agreement On HER-2 Breast Cancer Test.
Myriad Wins Patent For p10 Tumor Suppressor Gene.
Trending Stories
- With Anthony Letai’s appointment, NCI is now under new leadership—just in time for a shutdown
- Anthony G. Letai to be named NCI director
The Dana-Farber and Harvard physician-scientist is an inspired choice, colleagues say - Anthony Letai sworn in as 18th NCI director
- Dana-Farber/Harvard Cancer Center awarded $12M NIH SPORE grant to advance breast cancer research
- Population-based cancer surveillance is a national treasure at risk
- Former NCI official’s nonprofit seeks to tell the stories of cancer patients
Patient Action for Cancer Research aims to show impact of federal research